BioChem - DOS

L-proline transporter inhibitor (LQFM215) promotes neuroprotection in ischemic stroke

Pharmacological reports : Pr

Carvalho, Gustavo Almeida; Chiareli, Raphaela Almeida; Marques, Bruno Lemes; Parreira, Ricardo Cambraia; de Souza Gil, Eric; de Carvalho, Flá vio Silva; da Rocha, André Luí s Batista; Silva, Rafaela Ribeiro; Noë l, Franç ois; Vaz, Boniek Gontijo; Liã o, Luciano Morais; Ahmad, Shabir; Verli, Hugo; Menegatti, Ricardo; Pinto, Mauro Cunha Xavier

BACKGROUND: L-proline transporter (PROT/SLC6A7) is closely associated with glutamatergic neurotransmission, where L-proline modulates the NMDA receptor (NMDAR) function. NMDAR-mediated excitotoxicity is a primary cause of neuronal death following stroke, which is triggered by the uncontrolled release of glutamate during the ischemic process. After ischemic stroke, L-proline levels show a reduction in the plasma, but high circulating levels of this molecule indicate good functional recovery. This work aimed to produce new PROT inhibitors and explore their effects on ischemic stroke. METHODS: Initially, we built a three-dimensional model of the PROT protein and run a molecular docking with the newly designed compounds (LQFM215, LQFM216, and LQFM217). Then, we synthesized new PROT inhibitors by molecular hybridization, and proline uptake was measured in ex vivo and in vivo models. The behavioral characterization of the treated mice was performed by the open-field test, elevated plus-maze, Y-maze, and forced swimming test. We used the permanent middle cerebral artery occlusion (MCAO) model to study the ischemic stroke damage and analyzed the motor impairment with limb clasping or cylinder tests. RESULTS: LQFM215 inhibited proline uptake in hippocampal synaptosomes, and the LQFM215 treatment reduced proline levels in the mouse hippocampus. LQFM215 reduced the locomotor and exploratory activity in mice and did not show any anxiety-related or working memory impairments. In the MCAO model, LQFM215 pre-treatment and treatment reduced the infarcted area and reduced motor impairments in the cylinder test and limb clasping. CONCLUSIONS: This dataset suggests that the new compounds inhibit cerebral L-proline uptake and that LQFM215 promotes neuroprotection and neuro-repair in the acute ischemic stroke model.

2023

Springer-Verlag

1734-1140

2299-5684

75

2

pp.276-292

10.1007/s43440-023-00451-x

http://click.ndsl.kr/servlet/OpenAPIDetailView?keyValue=05787966&target=NART&cn=NART123588957